Friday, March 2, 2012
Bionovo Inc., of Emeryville, Calif., filed a registration statement to raise up to $25 million in convertible preferred stock and warrants to purchase shares of common stock. The offering is structured to be funded in four tranches. Bionovo, which earlier this month decided to explore strategic options, said prompt completion of the offering is critical to the company's continued operations throughout 2012.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.